REPORT ID 6416

Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2017

Publish Date
26-Dec-17
Pages
100
Format
Electronic (PDF)

In this report, the global Onychomycosis (Tinea Unguium) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Onychomycosis (Tinea Unguium) Drug in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Onychomycosis (Tinea Unguium) Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Johnson & Johnson
    GSK
    Novartis
    Pfizer
    Valeant Pharma
    Kaken Pharmaceutical
    Galderma
    Xiuzheng Pharmaceutical
    Letai
    Qilu Pharmaceutical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Oral Type
    External Use Type
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Age under 18
    Age 18-50
    Age above 50

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2017
1 Onychomycosis (Tinea Unguium) Drug Market Overview
    1.1 Product Overview and Scope of Onychomycosis (Tinea Unguium) Drug
    1.2 Onychomycosis (Tinea Unguium) Drug Segment by Type (Product Category)
        1.2.1 Global Onychomycosis (Tinea Unguium) Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Onychomycosis (Tinea Unguium) Drug Production Market Share by Type (Product Category) in 2016
        1.2.3 Oral Type
        1.2.4 External Use Type
    1.3 Global Onychomycosis (Tinea Unguium) Drug Segment by Application
        1.3.1 Onychomycosis (Tinea Unguium) Drug Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Age under 18
        1.3.3 Age 18-50
        1.3.4 Age above 50
    1.4 Global Onychomycosis (Tinea Unguium) Drug Market by Region (2012-2022)
        1.4.1 Global Onychomycosis (Tinea Unguium) Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Onychomycosis (Tinea Unguium) Drug (2012-2022)
        1.5.1 Global Onychomycosis (Tinea Unguium) Drug Revenue Status and Outlook (2012-2022)
        1.5.2 Global Onychomycosis (Tinea Unguium) Drug Capacity, Production Status and Outlook (2012-2022)

2 Global Onychomycosis (Tinea Unguium) Drug Market Competition by Manufacturers
    2.1 Global Onychomycosis (Tinea Unguium) Drug Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Onychomycosis (Tinea Unguium) Drug Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Onychomycosis (Tinea Unguium) Drug Production and Share by Manufacturers (2012-2017)
    2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Onychomycosis (Tinea Unguium) Drug Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Onychomycosis (Tinea Unguium) Drug Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Onychomycosis (Tinea Unguium) Drug Market Competitive Situation and Trends
        2.5.1 Onychomycosis (Tinea Unguium) Drug Market Concentration Rate
        2.5.2 Onychomycosis (Tinea Unguium) Drug Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Onychomycosis (Tinea Unguium) Drug Capacity and Market Share by Region (2012-2017)
    3.2 Global Onychomycosis (Tinea Unguium) Drug Production and Market Share by Region (2012-2017)
    3.3 Global Onychomycosis (Tinea Unguium) Drug Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Onychomycosis (Tinea Unguium) Drug Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Onychomycosis (Tinea Unguium) Drug Consumption by Region (2012-2017)
    4.2 North America Onychomycosis (Tinea Unguium) Drug Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Onychomycosis (Tinea Unguium) Drug Production, Consumption, Export, Import (2012-2017)
    4.4 China Onychomycosis (Tinea Unguium) Drug Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Onychomycosis (Tinea Unguium) Drug Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Onychomycosis (Tinea Unguium) Drug Production, Consumption, Export, Import (2012-2017)
    4.7 India Onychomycosis (Tinea Unguium) Drug Production, Consumption, Export, Import (2012-2017)

5 Global Onychomycosis (Tinea Unguium) Drug Production, Revenue (Value), Price Trend by Type
    5.1 Global Onychomycosis (Tinea Unguium) Drug Production and Market Share by Type (2012-2017)
    5.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2012-2017)
    5.3 Global Onychomycosis (Tinea Unguium) Drug Price by Type (2012-2017)
    5.4 Global Onychomycosis (Tinea Unguium) Drug Production Growth by Type (2012-2017)

6 Global Onychomycosis (Tinea Unguium) Drug Market Analysis by Application
    6.1 Global Onychomycosis (Tinea Unguium) Drug Consumption and Market Share by Application (2012-2017)
    6.2 Global Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Onychomycosis (Tinea Unguium) Drug Manufacturers Profiles/Analysis
    7.1 Johnson & Johnson
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 GSK
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 GSK Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Novartis
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Pfizer
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Valeant Pharma
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Kaken Pharmaceutical
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Galderma
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Xiuzheng Pharmaceutical
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Letai
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Letai Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Qilu Pharmaceutical
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Onychomycosis (Tinea Unguium) Drug Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview

8 Onychomycosis (Tinea Unguium) Drug Manufacturing Cost Analysis
    8.1 Onychomycosis (Tinea Unguium) Drug Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Onychomycosis (Tinea Unguium) Drug Market Forecast (2017-2022)
    12.1 Global Onychomycosis (Tinea Unguium) Drug Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Onychomycosis (Tinea Unguium) Drug Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Onychomycosis (Tinea Unguium) Drug Price and Trend Forecast (2017-2022)
    12.2 Global Onychomycosis (Tinea Unguium) Drug Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Onychomycosis (Tinea Unguium) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Onychomycosis (Tinea Unguium) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Onychomycosis (Tinea Unguium) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Onychomycosis (Tinea Unguium) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Onychomycosis (Tinea Unguium) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Onychomycosis (Tinea Unguium) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Onychomycosis (Tinea Unguium) Drug Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer